AIM Step 10
4th Year MBBS
Neuroscience
4th Year MBBS
Neuroscience
Student Memory Support
Substance Use Disorders, Alcohol and Addiction Pharmacology
High-yield memory reinforcement for rapid KMU revision. :contentReference[oaicite:0]{index=0}
1. High-Yield Flashcards
Tap each question to reveal the answer.
Q: What best distinguishes addiction from physiological dependence?
A: Addiction involves compulsive drug-seeking despite harm; dependence refers to physiological adaptation with withdrawal on cessation.
Q: What is tolerance?
A: A larger amount of a drug is needed to produce an effect previously produced by a smaller amount.
Q: What is cross-tolerance?
A: Tolerance to one drug reduces responsiveness to another drug with similar pharmacological actions.
Q: What is reverse tolerance or sensitization?
A: Repeated exposure produces an increased response to the same amount of drug.
Q: What is cross-dependence?
A: One related drug suppresses withdrawal caused by another drug with similar CNS effects.
Q: Which reward pathway is central to reinforcement in addiction?
A: The mesolimbic dopamine pathway, especially the ventral tegmental area to nucleus accumbens projection.
Q: Which nicotine-cessation drug is a partial agonist at α4β2 nicotinic receptors?
A: Varenicline.
Q: How does bupropion help smoking cessation?
A: It inhibits noradrenaline and dopamine reuptake and reduces nicotine craving and withdrawal.
Q: What is the main pharmacological approach to cannabis dependence?
A: There is no equivalent established specific cessation drug; medication is mainly symptom-directed alongside behavioural support.
Q: Which two enzymes form the main ethanol oxidation pathway?
A: Alcohol dehydrogenase converts ethanol to acetaldehyde; aldehyde dehydrogenase converts acetaldehyde to acetate.
Q: Which microsomal enzyme is induced by chronic alcohol exposure?
A: CYP2E1.
Q: How does ethanol produce CNS depression?
A: It enhances inhibitory signalling and reduces NMDA-mediated excitatory neurotransmission.
Q: What causes the disulfiram-alcohol reaction?
A: Aldehyde dehydrogenase inhibition causes acetaldehyde accumulation after alcohol intake.
Q: Which drug class is central to treatment of significant alcohol withdrawal?
A: Benzodiazepines.
Q: How do naltrexone and acamprosate differ in alcohol dependence treatment?
A: Naltrexone reduces reward through opioid-receptor blockade; acamprosate helps stabilize altered excitatory and inhibitory neurotransmission after withdrawal.
Q: What does a positive forensic toxicology result prove by itself?
A: It proves exposure; impairment, poisoning or causation requires correlation with other evidence.
2. Mnemonics
Mnemonic Title: Alcohol Dependence Drug Roles
BAND
Meaning: Benzodiazepines = withdrawal; Acamprosate = abstinence support; Naltrexone = reduced reward; Disulfiram = deterrent reaction.
Mnemonic Title: Nicotine Cessation Medicines
NBV
Meaning: Nicotine replacement, Bupropion, Varenicline.
Mnemonic Title: Forensic Narcotics Case Sequence
HESCI
Meaning: History/scene → Examination → Specimens/evidence → Chain of custody → Interpret toxicology in context.
3. Memory Tables
Tolerance-Related Concepts
| Concept | Key Memory Point |
|---|---|
| Tolerance | Larger amount needed for the same effect |
| Cross-tolerance | Tolerance to one drug reduces response to a related drug |
| Sensitization | Same amount produces a greater response after repeated exposure |
| Cross-dependence | A related drug suppresses withdrawal from another drug |
Alcohol Pharmacotherapy
| Drug | Main Role | Key Mechanism |
|---|---|---|
| Benzodiazepines | Withdrawal | Enhance GABA-mediated inhibition |
| Naltrexone | Reduce reinforcement | Opioid-receptor blockade |
| Acamprosate | Maintain abstinence | Modulates excitatory/inhibitory imbalance |
| Disulfiram | Aversive deterrent | Inhibits aldehyde dehydrogenase |
4. Rapid Revision Points — Last-Minute Revision
Must Remember:
- Mesolimbic dopamine signalling is central to reinforcement in addiction.
- Rapid delivery to the brain generally increases reinforcing potential.
- Varenicline is a partial agonist at α4β2 nicotinic receptors.
- Bupropion reduces nicotine craving through noradrenaline and dopamine effects.
- Ethanol is converted to acetaldehyde, then acetate.
- Chronic alcohol exposure induces CYP2E1.
- Severe alcohol withdrawal may progress to seizures and delirium.
- Disulfiram causes acetaldehyde accumulation if alcohol is consumed.
- Cannabis dependence has no equivalent established cessation drug comparable with varenicline.
- Positive toxicology establishes exposure but does not alone establish causation.
KMU Exam Trap: Physical dependence and tolerance can occur without compulsive drug-seeking; therefore they do not by themselves establish addiction.
5. Clinical Memory Hooks
Heavy alcohol use → abrupt cessation → compensatory CNS hyperexcitability causing tremor, agitation, seizures or delirium.
Alcohol consumed with disulfiram → aldehyde dehydrogenase inhibition → acetaldehyde accumulation → flushing, nausea and palpitations.
Smoker wants less craving and less reward from cigarettes → varenicline partial agonism at α4β2 nicotinic receptors.
Dance-club use + hyperthermia + altered behaviour → consider MDMA-related monoamine effects.
Drug detected on forensic toxicology → exposure is established, but impairment or cause of death still requires contextual interpretation.
6. Starred High-Yield Exam Points
- ⭐ Addiction is compulsive drug-seeking despite harm; dependence alone is not addiction.
- ⭐ The mesolimbic dopamine pathway is the key reward pathway linked with addictive reinforcement.
- ⭐ Ethanol metabolism: alcohol dehydrogenase → acetaldehyde; aldehyde dehydrogenase → acetate.
- ⭐ Benzodiazepines are central to treatment of significant alcohol withdrawal because they restore inhibitory GABAergic activity.
- ⭐ Disulfiram inhibits aldehyde dehydrogenase and causes an aversive acetaldehyde reaction with alcohol.
- ⭐ Varenicline partially stimulates α4β2 receptors, reducing both nicotine withdrawal and the rewarding effect of smoking.
- ⭐ In forensic toxicology, a positive drug result proves exposure but does not by itself prove impairment, poisoning or cause of death.